The company signed the agreement with Karolinska Institutet's Department of Cell and Molecular Biology professor Johan Ericson.

The lab of Dr. Mark Magnuson, Louise B. McGavock Professor and professor of molecular physiology and biophysics at Vanderbilt ...

A recent study comparing young and aged mouse intestinal tissues revealed a delicate balance between IFN-γ signaling and ERK/MAPK signaling as crucial for maintaining the intestinal stem cell ...

A guardian molecule ensures that liver cells do not lose their identity. This has been discovered by researchers from the German Cancer Research Center (DKFZ), the Hector Institute für Translational ...

Elixirgen Therapeutics, Inc. is a clinical-stage biotechnology company focused on the treatment of rare diseases and aging-associated diseases using its ZSCAN4 technology and mRNA platform ...

Scientists uncover how the nucleolus, a tiny structure within cells, may control aging and lifespan, opening new ...

In a recent study, researchers demonstrated that Z526, a novel dithiocarbamate-like compound, mitigates cancer-associated cachexia (CAC) both in vitro and in vivo.

What makes the human brain unique? A Yale study unlocks new insights into genetic changes that shaped our evolution.

International Day of Women & Girls in Science. ThePrint spoke to women scientists about their journeys & challenges in ...

Vertex has entered a reimbursement agreement with NHS England enabling eligible SCD patients to access Casgevy in the public ...

Vimentin is a type III intermediate filament (IF) protein normally expressed in cells that develop into connective tissue, ...